Vaxcyte, Inc. financial data

Symbol
PCVX on Nasdaq
Location
825 Industrial Road, Ste. 300, San Carlos, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.44K % +7.26%
Debt-to-equity 5.85 % -17.6%
Return On Equity -16.9 % +44%
Return On Assets -15.9 % +43.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130M shares +16.3%
Common Stock, Shares, Outstanding 130M shares +17.4%
Entity Public Float 7.2B USD +75.6%
Common Stock, Value, Issued 133K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 136M shares +16%
Weighted Average Number of Shares Outstanding, Diluted 136M shares +16%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 593M USD +38.6%
General and Administrative Expense 116M USD +56%
Operating Income (Loss) -709M USD -22.9%
Nonoperating Income (Expense) 59.6M USD +146%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -547M USD -10.1%
Earnings Per Share, Basic -4 USD/shares +12.4%
Earnings Per Share, Diluted -4 USD/shares +12.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 307M USD -40.9%
Other Assets, Current 4.46M USD +111%
Assets, Current 1.72B USD +15.8%
Property, Plant and Equipment, Net 242M USD +92.3%
Operating Lease, Right-of-Use Asset 85.6M USD +220%
Other Assets, Noncurrent 95.3M USD +80.8%
Assets 3.31B USD +58.4%
Accounts Payable, Current 31.4M USD +200%
Employee-related Liabilities, Current 10.8M USD +67.6%
Accrued Liabilities, Current 32.2M USD +45.4%
Liabilities, Current 154M USD +86.5%
Operating Lease, Liability, Noncurrent 79.5M USD +335%
Other Liabilities, Noncurrent 100K USD
Liabilities 234M USD +131%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.89M USD -204%
Retained Earnings (Accumulated Deficit) -1.7B USD -47.7%
Stockholders' Equity Attributable to Parent 3.07B USD +54.6%
Liabilities and Equity 3.31B USD +58.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -166M USD -4.49%
Net Cash Provided by (Used in) Financing Activities 759K USD -99.9%
Net Cash Provided by (Used in) Investing Activities 123M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 130M shares +17.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -41M USD -119%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 308M USD -40.7%
Deferred Tax Assets, Valuation Allowance 446M USD +54.8%
Deferred Tax Assets, Gross 468M USD +57.4%
Operating Lease, Liability 85.8M USD +236%
Payments to Acquire Property, Plant, and Equipment 5.42M USD -4.47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -551M USD -11.8%
Lessee, Operating Lease, Liability, to be Paid 121M USD +274%
Property, Plant and Equipment, Gross 214M USD +141%
Operating Lease, Liability, Current 6.3M USD -13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.8M USD +273%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.9M USD +20.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -11.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35.1M USD +421%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.8M USD +296%
Deferred Tax Assets, Operating Loss Carryforwards 196M USD +44.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.53M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.2M USD +296%
Operating Lease, Payments 12.9M USD +46.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.96M USD +196%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%